title: Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study.
abstract: OBJECTIVE
  Bacteraemia in dialysis units accounts for major morbidity, mortality, and antibiotic usage. Risk is much greater when lines rather than fistulas are used for haemodialysis. Surveillance is critical for infection control, but no standardised surveillance scheme exists in the United Kingdom.
  
  
  METHODS
  Prospective study in a London dialysis unit of the implementation and applicability of a dialysis associated bacteraemia surveillance scheme developed in the United States and its effect on bacteraemia, antibiotic usage, and admission.
  
  
  METHODS
  Hammersmith Hospital dialysis unit, London, where 112 outpatients receive dialysis three times weekly. Between June 2002 and December 2004, 3418 patient months of data were collected.
  
  
  METHODS
  Successful adoption of the scheme and reductions in bacteraemia rates, antibiotic usage, and admission to hospital. Strategy for improvement Embedding the surveillance scheme in the unit's clinical activity.
  
  
  RESULTS
  Raised awareness of bacteraemia prevention, prudent antibiotic prescribing, and the need for improved provision of vascular access. The scheme required two hours a month of consultant time. Significant downward trends were seen in bacteraemia rates and antibiotic usage: mean rate ratios from quarter to quarter 0.90 (95% confidence interval 0.85 to 0.94) and 0.91 (0.87 to 0.96), respectively. The rate of admission to hospital also showed a significant downward trend, with admissions directly connected to access related infection declining more rapidly: mean rate ratio of successive quarters 0.90 (0.84 to 0.96). The overall proportion of patients dialysed through catheters was significantly higher than in US outpatient centres (62.3% v 29.4%, P < 0.01). Study data were successfully used in a business case to improve access provision.
  
  
  CONCLUSIONS
  Dialysis specific surveillance of bacteraemia is critical to infection control in dialysis units and improving quality of care. Such a scheme could be adopted across the United Kingdom.
authors.affiliation: Renal Unit, Hammersmith Hospitals NHS Trust.
authors.forename: Abraham
authors.initials: A
authors.lastname: George
authors.forename: Jerome I
authors.initials: JI
authors.lastname: Tokars
authors.forename: Elaine J
authors.initials: EJ
authors.lastname: Clutterbuck
authors.forename: Kathleen B
authors.initials: KB
authors.lastname: Bamford
authors.forename: Charles
authors.initials: C
authors.lastname: Pusey
authors.forename: Alison H
authors.initials: AH
authors.lastname: Holmes
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000517:prevention & control*; D002408:Catheters, Indwelling / Q000706:statistics & numerical data; D003428:Cross Infection / Q000517:prevention & control; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D017053:Infection Control / Q000379:methods*; D008131:London; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects* / Q000379:methods; D012307:Risk Factors; D006113:United Kingdom
chemical_list: D000900:Anti-Bacterial Agents